Alpha Tau Successfully Treats First Recurrent Glioblastoma Patient Outside of the United States with Alpha DaRT® at Hadassah University Medical Center in Israel

Alpha Tau Medical successfully treated the first recurrent glioblastoma patient outside the U.S. using its Alpha DaRT technology at Hadassah University Medical Center in Israel. The procedure utilized the company's proprietary brain applicator and stereotactic neuro-navigation to deliver radiation sources via a minimally invasive burr hole, with no unexpected complications reported. This milestone supports the ongoing broad-access ALL protocol and adds momentum to the U.S.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.